01:03 , Jan 12, 2019 |  BioCentury  |  Finance

Warning: cash needed

  A near decade-long run of cheap money appears to be coming to a close, and most of the biotech sector isn’t well positioned for the new reality. BioCentury’s analysis shows that two-thirds of biotech...
01:12 , Aug 2, 2014 |  BC Extra  |  Financial News

Gen9 raises $25 million in undisclosed venture round

Synthetic biology company Gen9 Inc. (Cambridge, Mass.) raised $25 million from undisclosed investors in an undisclosed venture round. CEO Kevin Munnelly confirmed that the $25 million is in addition to a $21 million series C...
07:00 , Jul 29, 2013 |  BC Week In Review  |  Company News

Gen9, Johns Hopkins University genomics news

Synthetic biology company Gen9 will use its BioFab platform in the Synthetic Yeast Project Sc2.0 organized by the university's School of Medicine. Members of the project are building synthetic yeast chromosomes to assemble an engineered...
00:01 , Apr 25, 2013 |  BC Extra  |  Financial News

Gen9 raises $21 million from Agilent

Synthetic biology company Gen9 Inc. (Cambridge, Mass.) raised $21 million in a series C round from tool company Agilent Technologies Inc. (NYSE:A). Gen9's BioFab platform comprises gene synthesis technologies that the company said enables high...
07:00 , Apr 21, 2008 |  BioCentury  |  Strategy

Sticking to front-end value

Since it was founded in 2004, Codon Devices Inc. has used its BioFAB technology to provide synthetic gene constructs on a fee-for-service basis to customers in the pharmaceutical, agbiotech and industrial biotech markets. Last week,...
07:00 , Jul 2, 2007 |  BC Week In Review  |  Company News

Codon Devices, Open Biosystems Inc. sales and marketing update

Open Biosystems will distribute Codon's BioFAB gene synthesis product to researchers who fall below Codon's minimum order threshold. Codon will continue to market the product to customers who have large-scale requirements and reach the minimum...
01:32 , Dec 19, 2006 |  BC Extra  |  Financial News

Codon raises $20 million

Biomanufacturing company Codon Devices ( Cambridge , Mass.) raised $20 million in a series B round led by Highland Capital Partners. Existing investors Alloy Ventures; Flagship Ventures; Khosla Ventures; and Kleiner Perkins Caufield & Byers...